KTTA

Pasithea Therapeutics Corp.$0.48+0.00 (+0.28%)

Prev Close$0.48·MCap$6.0M·P/E—·Vol382.1K·Yield—

▲

Buys (12M)

$178.0K

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$178.0K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Pasithea Therapeutics Corp. (KTTA) has been exclusively buying, with 3 insider purchases totaling $178.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Coastlands Capital LP (10 percent owner), who purchased $53.0K worth of shares on Jun 22, 2026. Pasithea Therapeutics Corp. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.0M.

KTTA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 22, 2026	Coastlands Capital LP	10 percent owner	Buy	100,000	$0.53	$53.0K1.3% OS	3,835,035
Nov 28, 2025	Marques Tiago	Chief Executive Officer	Buy	33,333	$0.75	$25.0K	0
Nov 28, 2025	STEINMAN LAWRENCE	Director	Buy	133,333	$0.75	$100.0K1.8% OS	0
May 14, 2025	Marques Tiago	Chief Executive Officer	Sell	960	$0.83	$792.00	40,001

KTTA Insider Buying Activity

The following table shows recent insider purchases of Pasithea Therapeutics Corp. (KTTA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 22, 2026	Coastlands Capital LP	10 percent owner	Buy	100,000	$0.53	$53.0K1.3% OS	3,835,035
Nov 28, 2025	Marques Tiago	Chief Executive Officer	Buy	33,333	$0.75	$25.0K	0
Nov 28, 2025	STEINMAN LAWRENCE	Director	Buy	133,333	$0.75	$100.0K1.8% OS	0